Industry Research Reports

Home > Reports > Pharma & Healthcare > Sexual Dysfunction Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Sexual Dysfunction Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 135 Pages

Report ld: 2343943

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.

The global market for Sexual Dysfunction Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Sexual Dysfunction Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sexual Dysfunction Drugs by region & country, by Type, and by User.

The Sexual Dysfunction Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexual Dysfunction Drugs.

Market Segmentation

Report Metric
Details
Report Title
Sexual Dysfunction Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Sexual Dysfunction Drugs Companies Covered
Pfizer, GlaxoSmithKline, Merck, Eli Lilly, AbbVie, Bayer, Teva Pharmaceutical Industries, Takeda, Apricus Biosciences, Emotional Brain, Ivix LLX, Leadiant Biosciences, NexMed, S1 Biopharma, Vietstar Biomedical Research
Global Sexual Dysfunction Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sexual Dysfunction Drugs Market, Segment by Type
Oral Therapy

Intracavernosal Therapy

Hormonal Therapy

Transurethral Therapy
Global Sexual Dysfunction Drugs Market, Segment by Application
Male

Female
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sexual Dysfunction Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sexual Dysfunction Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sexual Dysfunction Drugs in country level. It provides sigmate data by Type, and by User for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Sexual Dysfunction Drugs Product Introduction
    1.2 Global Sexual Dysfunction Drugs Market Size Forecast
        1.2.1 Global Sexual Dysfunction Drugs Sales Value (2019-2030)
        1.2.2 Global Sexual Dysfunction Drugs Sales Volume (2019-2030)
        1.2.3 Global Sexual Dysfunction Drugs Sales Price (2019-2030)
    1.3 Sexual Dysfunction Drugs Market Trends & Drivers
        1.3.1 Sexual Dysfunction Drugs Industry Trends
        1.3.2 Sexual Dysfunction Drugs Market Drivers & Opportunity
        1.3.3 Sexual Dysfunction Drugs Market Challenges
        1.3.4 Sexual Dysfunction Drugs Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Sexual Dysfunction Drugs Players Revenue Ranking (2023)
    2.2 Global Sexual Dysfunction Drugs Revenue by Company (2019-2024)
    2.3 Global Sexual Dysfunction Drugs Players Sales Volume Ranking (2023)
    2.4 Global Sexual Dysfunction Drugs Sales Volume by Company Players (2019-2024)
    2.5 Global Sexual Dysfunction Drugs Average Price by Company (2019-2024)
    2.6 Key Manufacturers Sexual Dysfunction Drugs Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Sexual Dysfunction Drugs Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Sexual Dysfunction Drugs
    2.9 Sexual Dysfunction Drugs Market Competitive Analysis
        2.9.1 Sexual Dysfunction Drugs Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Sexual Dysfunction Drugs Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexual Dysfunction Drugs as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Oral Therapy
        3.1.2 Intracavernosal Therapy
        3.1.3 Hormonal Therapy
        3.1.4 Transurethral Therapy
    3.2 Global Sexual Dysfunction Drugs Sales Value by Type
        3.2.1 Global Sexual Dysfunction Drugs Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Sexual Dysfunction Drugs Sales Value, by Type (2019-2030)
        3.2.3 Global Sexual Dysfunction Drugs Sales Value, by Type (%) (2019-2030)
    3.3 Global Sexual Dysfunction Drugs Sales Volume by Type
        3.3.1 Global Sexual Dysfunction Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Sexual Dysfunction Drugs Sales Volume, by Type (2019-2030)
        3.3.3 Global Sexual Dysfunction Drugs Sales Volume, by Type (%) (2019-2030)
    3.4 Global Sexual Dysfunction Drugs Average Price by Type (2019-2030)

 4 Segmentation by User
    4.1 Introduction by User
        4.1.1 Male
        4.1.2 Female
    4.2 Global Sexual Dysfunction Drugs Sales Value by User
        4.2.1 Global Sexual Dysfunction Drugs Sales Value by User (2019 VS 2023 VS 2030)
        4.2.2 Global Sexual Dysfunction Drugs Sales Value, by User (2019-2030)
        4.2.3 Global Sexual Dysfunction Drugs Sales Value, by User (%) (2019-2030)
    4.3 Global Sexual Dysfunction Drugs Sales Volume by User
        4.3.1 Global Sexual Dysfunction Drugs Sales Volume by User (2019 VS 2023 VS 2030)
        4.3.2 Global Sexual Dysfunction Drugs Sales Volume, by User (2019-2030)
        4.3.3 Global Sexual Dysfunction Drugs Sales Volume, by User (%) (2019-2030)
    4.4 Global Sexual Dysfunction Drugs Average Price by User (2019-2030)

 5 Segmentation by Region
    5.1 Global Sexual Dysfunction Drugs Sales Value by Region
        5.1.1 Global Sexual Dysfunction Drugs Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Sexual Dysfunction Drugs Sales Value by Region (2019-2024)
        5.1.3 Global Sexual Dysfunction Drugs Sales Value by Region (2025-2030)
        5.1.4 Global Sexual Dysfunction Drugs Sales Value by Region (%), (2019-2030)
    5.2 Global Sexual Dysfunction Drugs Sales Volume by Region
        5.2.1 Global Sexual Dysfunction Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Sexual Dysfunction Drugs Sales Volume by Region (2019-2024)
        5.2.3 Global Sexual Dysfunction Drugs Sales Volume by Region (2025-2030)
        5.2.4 Global Sexual Dysfunction Drugs Sales Volume by Region (%), (2019-2030)
    5.3 Global Sexual Dysfunction Drugs Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Sexual Dysfunction Drugs Sales Value, 2019-2030
        5.4.2 North America Sexual Dysfunction Drugs Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Sexual Dysfunction Drugs Sales Value, 2019-2030
        5.5.2 Europe Sexual Dysfunction Drugs Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Sexual Dysfunction Drugs Sales Value, 2019-2030
        5.6.2 Asia Pacific Sexual Dysfunction Drugs Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Sexual Dysfunction Drugs Sales Value, 2019-2030
        5.7.2 South America Sexual Dysfunction Drugs Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Sexual Dysfunction Drugs Sales Value, 2019-2030
        5.8.2 Middle East & Africa Sexual Dysfunction Drugs Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Sexual Dysfunction Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Sexual Dysfunction Drugs Sales Value
        6.2.1 Key Countries/Regions Sexual Dysfunction Drugs Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Sexual Dysfunction Drugs Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Sexual Dysfunction Drugs Sales Value, 2019-2030
        6.3.2 United States Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Sexual Dysfunction Drugs Sales Value by User, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Sexual Dysfunction Drugs Sales Value, 2019-2030
        6.4.2 Europe Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Sexual Dysfunction Drugs Sales Value by User, 2023 VS 2030
    6.5 China
        6.5.1 China Sexual Dysfunction Drugs Sales Value, 2019-2030
        6.5.2 China Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Sexual Dysfunction Drugs Sales Value by User, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Sexual Dysfunction Drugs Sales Value, 2019-2030
        6.6.2 Japan Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Sexual Dysfunction Drugs Sales Value by User, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Sexual Dysfunction Drugs Sales Value, 2019-2030
        6.7.2 South Korea Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Sexual Dysfunction Drugs Sales Value by User, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Sexual Dysfunction Drugs Sales Value, 2019-2030
        6.8.2 Southeast Asia Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Sexual Dysfunction Drugs Sales Value by User, 2023 VS 2030
    6.9 India
        6.9.1 India Sexual Dysfunction Drugs Sales Value, 2019-2030
        6.9.2 India Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Sexual Dysfunction Drugs Sales Value by User, 2023 VS 2030

 7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Company Information
        7.1.2 Pfizer Introduction and Business Overview
        7.1.3 Pfizer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Pfizer Sexual Dysfunction Drugs Product Offerings
        7.1.5 Pfizer Recent Development
    7.2 GlaxoSmithKline
        7.2.1 GlaxoSmithKline Company Information
        7.2.2 GlaxoSmithKline Introduction and Business Overview
        7.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 GlaxoSmithKline Sexual Dysfunction Drugs Product Offerings
        7.2.5 GlaxoSmithKline Recent Development
    7.3 Merck
        7.3.1 Merck Company Information
        7.3.2 Merck Introduction and Business Overview
        7.3.3 Merck Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Merck Sexual Dysfunction Drugs Product Offerings
        7.3.5 Merck Recent Development
    7.4 Eli Lilly
        7.4.1 Eli Lilly Company Information
        7.4.2 Eli Lilly Introduction and Business Overview
        7.4.3 Eli Lilly Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Eli Lilly Sexual Dysfunction Drugs Product Offerings
        7.4.5 Eli Lilly Recent Development
    7.5 AbbVie
        7.5.1 AbbVie Company Information
        7.5.2 AbbVie Introduction and Business Overview
        7.5.3 AbbVie Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 AbbVie Sexual Dysfunction Drugs Product Offerings
        7.5.5 AbbVie Recent Development
    7.6 Bayer
        7.6.1 Bayer Company Information
        7.6.2 Bayer Introduction and Business Overview
        7.6.3 Bayer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Bayer Sexual Dysfunction Drugs Product Offerings
        7.6.5 Bayer Recent Development
    7.7 Teva Pharmaceutical Industries
        7.7.1 Teva Pharmaceutical Industries Company Information
        7.7.2 Teva Pharmaceutical Industries Introduction and Business Overview
        7.7.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Offerings
        7.7.5 Teva Pharmaceutical Industries Recent Development
    7.8 Takeda
        7.8.1 Takeda Company Information
        7.8.2 Takeda Introduction and Business Overview
        7.8.3 Takeda Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Takeda Sexual Dysfunction Drugs Product Offerings
        7.8.5 Takeda Recent Development
    7.9 Apricus Biosciences
        7.9.1 Apricus Biosciences Company Information
        7.9.2 Apricus Biosciences Introduction and Business Overview
        7.9.3 Apricus Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Apricus Biosciences Sexual Dysfunction Drugs Product Offerings
        7.9.5 Apricus Biosciences Recent Development
    7.10 Emotional Brain
        7.10.1 Emotional Brain Company Information
        7.10.2 Emotional Brain Introduction and Business Overview
        7.10.3 Emotional Brain Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Emotional Brain Sexual Dysfunction Drugs Product Offerings
        7.10.5 Emotional Brain Recent Development
    7.11 Ivix LLX
        7.11.1 Ivix LLX Company Information
        7.11.2 Ivix LLX Introduction and Business Overview
        7.11.3 Ivix LLX Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Ivix LLX Sexual Dysfunction Drugs Product Offerings
        7.11.5 Ivix LLX Recent Development
    7.12 Leadiant Biosciences
        7.12.1 Leadiant Biosciences Company Information
        7.12.2 Leadiant Biosciences Introduction and Business Overview
        7.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Leadiant Biosciences Sexual Dysfunction Drugs Product Offerings
        7.12.5 Leadiant Biosciences Recent Development
    7.13 NexMed
        7.13.1 NexMed Company Information
        7.13.2 NexMed Introduction and Business Overview
        7.13.3 NexMed Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 NexMed Sexual Dysfunction Drugs Product Offerings
        7.13.5 NexMed Recent Development
    7.14 S1 Biopharma
        7.14.1 S1 Biopharma Company Information
        7.14.2 S1 Biopharma Introduction and Business Overview
        7.14.3 S1 Biopharma Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 S1 Biopharma Sexual Dysfunction Drugs Product Offerings
        7.14.5 S1 Biopharma Recent Development
    7.15 Vietstar Biomedical Research
        7.15.1 Vietstar Biomedical Research Company Information
        7.15.2 Vietstar Biomedical Research Introduction and Business Overview
        7.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 Vietstar Biomedical Research Sexual Dysfunction Drugs Product Offerings
        7.15.5 Vietstar Biomedical Research Recent Development

 8 Industry Chain Analysis
    8.1 Sexual Dysfunction Drugs Industrial Chain
    8.2 Sexual Dysfunction Drugs Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Sexual Dysfunction Drugs Sales Model
        8.5.2 Sales Channel
        8.5.3 Sexual Dysfunction Drugs Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Sexual Dysfunction Drugs Market Trends
    Table 2. Sexual Dysfunction Drugs Market Drivers & Opportunity
    Table 3. Sexual Dysfunction Drugs Market Challenges
    Table 4. Sexual Dysfunction Drugs Market Restraints
    Table 5. Global Sexual Dysfunction Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Sexual Dysfunction Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Sexual Dysfunction Drugs Sales Volume by Company (2019-2024) & (K Pcs)
    Table 8. Global Sexual Dysfunction Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Sexual Dysfunction Drugs Price by Company (2019-2024) & (USD/Pcs)
    Table 10. Key Manufacturers Sexual Dysfunction Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Sexual Dysfunction Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Sexual Dysfunction Drugs
    Table 13. Global Sexual Dysfunction Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexual Dysfunction Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Sexual Dysfunction Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Sexual Dysfunction Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Sexual Dysfunction Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Sexual Dysfunction Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Sexual Dysfunction Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Sexual Dysfunction Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Pcs)
    Table 22. Global Sexual Dysfunction Drugs Sales Volume by Type (2019-2024) & (K Pcs)
    Table 23. Global Sexual Dysfunction Drugs Sales Volume by Type (2025-2030) & (K Pcs)
    Table 24. Global Sexual Dysfunction Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Sexual Dysfunction Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Sexual Dysfunction Drugs Price by Type (2019-2024) & (USD/Pcs)
    Table 27. Global Sexual Dysfunction Drugs Price by Type (2025-2030) & (USD/Pcs)
    Table 28. Global Sexual Dysfunction Drugs Sales Value by User: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Sexual Dysfunction Drugs Sales Value by User (2019-2024) & (US$ Million)
    Table 30. Global Sexual Dysfunction Drugs Sales Value by User (2025-2030) & (US$ Million)
    Table 31. Global Sexual Dysfunction Drugs Sales Market Share in Value by User (2019-2024) & (%)
    Table 32. Global Sexual Dysfunction Drugs Sales Market Share in Value by User (2025-2030) & (%)
    Table 33. Global Sexual Dysfunction Drugs Sales Volume by User: 2019 VS 2023 VS 2030 (K Pcs)
    Table 34. Global Sexual Dysfunction Drugs Sales Volume by User (2019-2024) & (K Pcs)
    Table 35. Global Sexual Dysfunction Drugs Sales Volume by User (2025-2030) & (K Pcs)
    Table 36. Global Sexual Dysfunction Drugs Sales Market Share in Volume by User (2019-2024) & (%)
    Table 37. Global Sexual Dysfunction Drugs Sales Market Share in Volume by User (2025-2030) & (%)
    Table 38. Global Sexual Dysfunction Drugs Price by User (2019-2024) & (USD/Pcs)
    Table 39. Global Sexual Dysfunction Drugs Price by User (2025-2030) & (USD/Pcs)
    Table 40. Global Sexual Dysfunction Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Sexual Dysfunction Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Sexual Dysfunction Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Sexual Dysfunction Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Sexual Dysfunction Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Sexual Dysfunction Drugs Sales Volume by Region (K Pcs): 2019 VS 2023 VS 2030
    Table 46. Global Sexual Dysfunction Drugs Sales Volume by Region (2019-2024) & (K Pcs)
    Table 47. Global Sexual Dysfunction Drugs Sales Volume by Region (2025-2030) & (K Pcs)
    Table 48. Global Sexual Dysfunction Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Sexual Dysfunction Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Sexual Dysfunction Drugs Average Price by Region (2019-2024) & (USD/Pcs)
    Table 51. Global Sexual Dysfunction Drugs Average Price by Region (2025-2030) & (USD/Pcs)
    Table 52. Key Countries/Regions Sexual Dysfunction Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Sexual Dysfunction Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Sexual Dysfunction Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Sexual Dysfunction Drugs Sales Volume, (2019-2024) & (K Pcs)
    Table 56. Key Countries/Regions Sexual Dysfunction Drugs Sales Volume, (2025-2030) & (K Pcs)
    Table 57. Pfizer Company Information
    Table 58. Pfizer Introduction and Business Overview
    Table 59. Pfizer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 60. Pfizer Sexual Dysfunction Drugs Product Offerings
    Table 61. Pfizer Recent Development
    Table 62. GlaxoSmithKline Company Information
    Table 63. GlaxoSmithKline Introduction and Business Overview
    Table 64. GlaxoSmithKline Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 65. GlaxoSmithKline Sexual Dysfunction Drugs Product Offerings
    Table 66. GlaxoSmithKline Recent Development
    Table 67. Merck Company Information
    Table 68. Merck Introduction and Business Overview
    Table 69. Merck Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 70. Merck Sexual Dysfunction Drugs Product Offerings
    Table 71. Merck Recent Development
    Table 72. Eli Lilly Company Information
    Table 73. Eli Lilly Introduction and Business Overview
    Table 74. Eli Lilly Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 75. Eli Lilly Sexual Dysfunction Drugs Product Offerings
    Table 76. Eli Lilly Recent Development
    Table 77. AbbVie Company Information
    Table 78. AbbVie Introduction and Business Overview
    Table 79. AbbVie Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 80. AbbVie Sexual Dysfunction Drugs Product Offerings
    Table 81. AbbVie Recent Development
    Table 82. Bayer Company Information
    Table 83. Bayer Introduction and Business Overview
    Table 84. Bayer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 85. Bayer Sexual Dysfunction Drugs Product Offerings
    Table 86. Bayer Recent Development
    Table 87. Teva Pharmaceutical Industries Company Information
    Table 88. Teva Pharmaceutical Industries Introduction and Business Overview
    Table 89. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 90. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Offerings
    Table 91. Teva Pharmaceutical Industries Recent Development
    Table 92. Takeda Company Information
    Table 93. Takeda Introduction and Business Overview
    Table 94. Takeda Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 95. Takeda Sexual Dysfunction Drugs Product Offerings
    Table 96. Takeda Recent Development
    Table 97. Apricus Biosciences Company Information
    Table 98. Apricus Biosciences Introduction and Business Overview
    Table 99. Apricus Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 100. Apricus Biosciences Sexual Dysfunction Drugs Product Offerings
    Table 101. Apricus Biosciences Recent Development
    Table 102. Emotional Brain Company Information
    Table 103. Emotional Brain Introduction and Business Overview
    Table 104. Emotional Brain Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 105. Emotional Brain Sexual Dysfunction Drugs Product Offerings
    Table 106. Emotional Brain Recent Development
    Table 107. Ivix LLX Company Information
    Table 108. Ivix LLX Introduction and Business Overview
    Table 109. Ivix LLX Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 110. Ivix LLX Sexual Dysfunction Drugs Product Offerings
    Table 111. Ivix LLX Recent Development
    Table 112. Leadiant Biosciences Company Information
    Table 113. Leadiant Biosciences Introduction and Business Overview
    Table 114. Leadiant Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 115. Leadiant Biosciences Sexual Dysfunction Drugs Product Offerings
    Table 116. Leadiant Biosciences Recent Development
    Table 117. NexMed Company Information
    Table 118. NexMed Introduction and Business Overview
    Table 119. NexMed Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 120. NexMed Sexual Dysfunction Drugs Product Offerings
    Table 121. NexMed Recent Development
    Table 122. S1 Biopharma Company Information
    Table 123. S1 Biopharma Introduction and Business Overview
    Table 124. S1 Biopharma Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 125. S1 Biopharma Sexual Dysfunction Drugs Product Offerings
    Table 126. S1 Biopharma Recent Development
    Table 127. Vietstar Biomedical Research Company Information
    Table 128. Vietstar Biomedical Research Introduction and Business Overview
    Table 129. Vietstar Biomedical Research Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 130. Vietstar Biomedical Research Sexual Dysfunction Drugs Product Offerings
    Table 131. Vietstar Biomedical Research Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Sexual Dysfunction Drugs Downstream Customers
    Table 135. Sexual Dysfunction Drugs Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sexual Dysfunction Drugs Product Picture
    Figure 2. Global Sexual Dysfunction Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Sexual Dysfunction Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Sexual Dysfunction Drugs Sales Volume (2019-2030) & (K Pcs)
    Figure 5. Global Sexual Dysfunction Drugs Sales Price (2019-2030) & (USD/Pcs)
    Figure 6. Sexual Dysfunction Drugs Report Years Considered
    Figure 7. Global Sexual Dysfunction Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Sexual Dysfunction Drugs Players Sales Volume Ranking (2023) & (K Pcs)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sexual Dysfunction Drugs Revenue in 2023
    Figure 10. Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Oral Therapy Picture
    Figure 12. Intracavernosal Therapy Picture
    Figure 13. Hormonal Therapy Picture
    Figure 14. Transurethral Therapy Picture
    Figure 15. Global Sexual Dysfunction Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Sexual Dysfunction Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Sexual Dysfunction Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 18. Global Sexual Dysfunction Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Sexual Dysfunction Drugs Price by Type (2019-2030) & (USD/Pcs)
    Figure 20. Product Picture of Male
    Figure 21. Product Picture of Female
    Figure 22. Global Sexual Dysfunction Drugs Sales Value by User (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Sexual Dysfunction Drugs Sales Value Market Share by User, 2023 & 2030
    Figure 24. Global Sexual Dysfunction Drugs Sales Volume by User (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 25. Global Sexual Dysfunction Drugs Sales Volume Market Share by User, 2023 & 2030
    Figure 26. Global Sexual Dysfunction Drugs Price by User (2019-2030) & (USD/Pcs)
    Figure 27. North America Sexual Dysfunction Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Sexual Dysfunction Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Sexual Dysfunction Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Sexual Dysfunction Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Sexual Dysfunction Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Sexual Dysfunction Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Sexual Dysfunction Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Sexual Dysfunction Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Sexual Dysfunction Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Sexual Dysfunction Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Sexual Dysfunction Drugs Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Sexual Dysfunction Drugs Sales Volume (%), (2019-2030)
    Figure 39. United States Sexual Dysfunction Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Sexual Dysfunction Drugs Sales Value by User (%), 2023 VS 2030
    Figure 42. Europe Sexual Dysfunction Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Sexual Dysfunction Drugs Sales Value by User (%), 2023 VS 2030
    Figure 45. China Sexual Dysfunction Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Sexual Dysfunction Drugs Sales Value by User (%), 2023 VS 2030
    Figure 48. Japan Sexual Dysfunction Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Sexual Dysfunction Drugs Sales Value by User (%), 2023 VS 2030
    Figure 51. South Korea Sexual Dysfunction Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Sexual Dysfunction Drugs Sales Value by User (%), 2023 VS 2030
    Figure 54. Southeast Asia Sexual Dysfunction Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Sexual Dysfunction Drugs Sales Value by User (%), 2023 VS 2030
    Figure 57. India Sexual Dysfunction Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Sexual Dysfunction Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Sexual Dysfunction Drugs Sales Value by User (%), 2023 VS 2030
    Figure 60. Sexual Dysfunction Drugs Industrial Chain
    Figure 61. Sexual Dysfunction Drugs Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.

The global market for Sexual Dysfunction Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

Market Segmentation

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 135 Pages

Report ld: 2343943

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00